ABALLI JOHN 4
4 · EXAGEN INC. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
EXAGEN INC.XGN
ABALLI JOHN
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1]2026-02-24$3.61/sh−11,430$41,262→ 702,997 total
Holdings
- 40,401(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.
Signature
/s/ Jeffrey G. Black, as attorney-in-fact|2026-02-25